The effect of TAB duration and pelvic RT in prostate cancers with gleason score 8-10: TROG study
dc.contributor.author | Ozyigit, G. | |
dc.contributor.author | Onal, C. | |
dc.contributor.author | Igdem, S. | |
dc.contributor.author | Alicikus, Z. Arican | |
dc.contributor.author | Iribas, A. | |
dc.contributor.author | Akin, M. | |
dc.contributor.author | Yalman, D. | |
dc.contributor.author | Cetin, I. | |
dc.contributor.author | Aksu, M. G. | |
dc.contributor.author | Atalar, B. | |
dc.contributor.author | Dincbas, F. | |
dc.contributor.author | Aydin, B. | |
dc.contributor.author | Sert, F. | |
dc.contributor.author | Yildirim, C. | |
dc.contributor.author | Gorken, I. B. | |
dc.contributor.author | Agaoglu, F. Y. | |
dc.contributor.author | Korcum, A. F. | |
dc.contributor.author | Ozkok, S. | |
dc.contributor.author | Darendeliler, E. | |
dc.contributor.author | Akyol, F. | |
dc.date.accessioned | 2019-10-27T11:08:32Z | |
dc.date.available | 2019-10-27T11:08:32Z | |
dc.date.issued | 2017 | |
dc.department | Ege Üniversitesi | en_US |
dc.identifier.doi | 10.1016/S0167-8140(17)31171-4 | |
dc.identifier.endpage | S386 | en_US |
dc.identifier.issn | 0167-8140 | |
dc.identifier.issn | 1879-0887 | |
dc.identifier.startpage | S386 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0167-8140(17)31171-4 | |
dc.identifier.uri | https://hdl.handle.net/11454/32182 | |
dc.identifier.volume | 123 | en_US |
dc.identifier.wos | WOS:000467786301348 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.relation.ispartof | Radiotherapy and Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | The effect of TAB duration and pelvic RT in prostate cancers with gleason score 8-10: TROG study | en_US |
dc.type | Conference Object | en_US |